GlaxoSmithKlineE Balance Sheet Health
Financial Health criteria checks 6/6
GlaxoSmithKlineE has a total shareholder equity of EGP2.0B and total debt of EGP0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are EGP3.7B and EGP1.8B respectively. GlaxoSmithKlineE's EBIT is EGP435.5M making its interest coverage ratio -113.6. It has cash and short-term investments of EGP829.3M.
Key information
0%
Debt to equity ratio
ج.م0
Debt
Interest coverage ratio | -113.6x |
Cash | ج.م829.34m |
Equity | ج.م1.96b |
Total liabilities | ج.م1.75b |
Total assets | ج.م3.71b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BIOC's short term assets (EGP2.9B) exceed its short term liabilities (EGP1.7B).
Long Term Liabilities: BIOC's short term assets (EGP2.9B) exceed its long term liabilities (EGP70.5M).
Debt to Equity History and Analysis
Debt Level: BIOC is debt free.
Reducing Debt: BIOC had no debt 5 years ago.
Debt Coverage: BIOC has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: BIOC has no debt, therefore coverage of interest payments is not a concern.